BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Astute Medical’s Test for AKI Risk Assessment Could Lead to Safer ICU Care

  The study also showed distinct biomarker level increases indicating when major surgery and nonsteroidal anti-inflammatory drugs put patients at risk of AKI.

  December 27, 2017

   · 

  7 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Study Explores Impact of Obesity on Bone Marrow Cells

  New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity on the long-term health of blood-making stem cells.

  December 27, 2017

   · 

  2 min read
• Drug Development

  BiondVax Plans Phase III Clinical Trial Following Receipt of Scientific Advice From the EMA

  BiondVax announced today that the EMA’s CHMP reviewed BiondVax’s Phase 3 trial plan, provided advice, and allowed the Company to proceed with the Phase 3 clinical trial plan for M-001, BiondVax’s universal flu vaccine candidate.

  December 27, 2017

   · 

  4 min read
• Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States

  Atazanavir sulfate capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 6 years and older weighing at least 15 kg.

  December 27, 2017

   · 

  9 min read
• Pharm Country

  Up to 10 Percent Off for 2017 Christmas and the New Year From Creative BioMart

  Creative BioMart recently launched its biggest promotion of the year 2017 to celebrate the coming Christmas and the New Year.

  December 27, 2017

   · 

  1 min read
• BioMidwest

  Medizone International Attending the J.P. Morgan 36th Annual Healthcare Conference for Partnership and Investment Discussions

  Medizone announced today the Company’s management will be attending the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, January 8th through 11th.

  December 27, 2017

   · 

  2 min read
• Cochlear Implant Successfully Performed as Part of MOHAP’s Initiatives for the Year of Giving

  As part of the MOHAP initiatives of the Year of Giving, a cochlear implant was successfully performed for a 12-year-old Indian girl, who suffered from sudden hearing loss for a period of two years due to a severe viral infection that damaged the cochlear nerve.

  December 27, 2017

   · 

  1 min read
• 

  Policy

  SoCal’s Glaukos Files PMA Bid for iStent Inject Glaucoma Treatment

  The iStent inject is designed to improve aqueous humor outflow into Schlemm’s canal and reduce IOP in glaucoma patients undergoing cataract surgery.

  December 27, 2017

   · 

  7 min read
• 

  Business

  SoCal’s Peregrine Names a New CEO, to Change Name to Avid Bioservices

  Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests.

  December 27, 2017

   · 

  5 min read
• 

  FDA

  FDA Green Lights Anika’s Injectable HA-Based Bone Repair Treatment

  The treatment is indicated for filling bone voids or defects of the skeletal system.

  December 27, 2017

   · 

  6 min read